Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
LINC00384 (Long intergenic non-protein coding RNA 384) is a member of the long non-coding RNA (lncRNA) class, transcribed from intergenic regions and lacking protein-coding potential[1][3][7]. Its sequence and locus are documented in public genetic databases, but its biological functions, involvement in cellular processes, and relevance to human disease are currently uncharacterized. There is no established data supporting its role as a therapeutic target or biomarker. As of 2025, LINC00384 remains a little-studied gene with unknown physiological or pathological significance.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Long intergenic non-protein coding RNA 384 (LINC00384).